Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.1 to v3.3.2 appears on the page. This seems to be a minor site version update with no visible changes to study content or user-facing elements.
    Difference
    0.0%
    Check dated 2025-11-27T22:53:50.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The Publications section now notes auto-fill from PubMed and the page revision is updated to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-20T22:29:49.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Removed a general notice about government funding and NIH Clinical Center operations from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-13T16:51:57.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    No additions or deletions were detected; page content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T11:19:26.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Update of geographic region labels to Auvergne-Rhône-Alpes with city-level detail for Lyon (69008); replaces Rhône-Alpes references.
    Difference
    4%
    Check dated 2025-10-09T00:56:07.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    - Updated medical terminology from 'Medullary thyroid gland carcinoma' to 'Medullary thyroid carcinoma' and bumped version to v3.2.0.
    Difference
    0.1%
    Check dated 2025-10-01T04:51:24.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.